A Universal Influenza Vaccine: The Strategic Plan for the National Institute of Allergy and Infectious Diseases

Abstract

A priority for the National Institute of Allergy and Infectious Diseases is development of a universal influenza vaccine providing durable protection against multiple influenza strains. NIAID will use this strategic plan as a foundation for future investments in influenza research.